2000 Surveillance Slides
This is an archived document. The links
and content are no longer being updated.
Return to 2000 Surveillance Slides Main
Menu
Completion of TB Therapy
United States, 1993-1998
|
Slide 18: Completion of TB Therapy, United
States, 1993-1998. The individual TB case report began collecting
information on completion of therapy in 1993.
This slide is based on data received at CDC by April 2001.
Patients with an initial isolate resistant to rifampin and children
with meningeal, bone or joint, or miliary disease were excluded from the
calculations. Overall completion
remained at approximately 90%; however, completion of therapy in 1 year
or less increased from <65% in 1993 to nearly 80% in 1998.
The current national program goal is completion of therapy in 1
year or less in 90% of patients.
CDC is working with state and local health departments to evaluate
reasons for apparently delayed completion of therapy, which may vary by
jurisdiction. |
Back to 2000 Surveillance Slides Main Page
|
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Back to Top of Page
You will need Adobe Acrobat Reader
v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat Reader.
If you have difficulty accessing any
material on the DTBE Web site because of a disability, please contact
us in writing or via telephone and we will work with you to make the information
available.
Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov
|
Home |
Site Map
| Contact Us
Accessibility
| Privacy Policy Notice |
FOIA
| USA.gov
CDC Home |
Search |
Health Topics A-Z
Centers for Disease Control & Prevention
National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination Please send comments/suggestions/requests to:
CDCINFO@cdc.gov
|